Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine in Imatinib-Refractory Chronic Phase CML
NCT00042016Phase 2Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of decitabine in chronic myelogenous leukemia (CML), sponsored by Astex Pharmaceuticals. Started Jul 2002; status: completed.
02
Drugs
decitabine
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NCT00042016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042016.